Complications after radical gastrectomy following FOLFOX7 neoadjuvant chemotherapy for gastric cancer.
about
Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy.Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy.A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer.ABCC2-24C > T polymorphism is associated with the response to platinum/5-Fu-based neoadjuvant chemotherapy and better clinical outcomes in advanced gastric cancer patients.Perioperative chemotherapy in locally advanced gastric cancer.Comparative Investigation of Postoperative Complications in Patients With Gastroesophageal Junction Cancer Treated With Preoperative Chemotherapy or Surgery Alone.Comparison of postoperative complications in advanced head and neck cancer patients receiving neoadjuvant chemotherapy followed by surgery versus surgery alone.Laparoscopic versus open distal gastrectomy for locally advanced gastric cancer after neoadjuvant chemotherapy: safety and short-term oncologic results.The impact of neoadjuvant therapy for gastroesophageal adenocarcinoma on postoperative morbidity and mortality.Effect of neoadjuvant chemotherapy on postoperative morbidity and mortality in patients with locally advanced gastric cancer.Interaction of Postoperative Morbidity and Receipt of Adjuvant Therapy on Long-Term Survival After Resection for Gastric Adenocarcinoma: Results From the U.S. Gastric Cancer Collaborative.Adjuvant Therapy Completion Rates in Patients with Gastric Cancer Undergoing Perioperative Chemotherapy Versus a Surgery-First Approach.Survival Benefit of Perioperative Chemotherapy in Patients with Locally Advanced Gastric Cancer: a Propensity Score Matched Analysis.Radical Gastrectomy: Still the Cornerstone of Curative Treatment for Gastric Cancer in the Perioperative Chemotherapy Era-A Single Institute Experience over a Decade.
P2860
Q35060024-C60C4E1C-D8E2-4AEC-A05F-F82693127041Q36881262-0FD104CD-910E-49BF-8B31-D9F7B1A65548Q37174037-BD8A450B-0242-478C-AB7A-E8FA5A5AE579Q37688251-82D3C480-6D9A-4D28-B611-63F2EFEE75D6Q38169894-23114F0E-C957-4848-915B-D78EF827C64EQ39026949-517EA797-F839-4141-BFF1-08D712109B49Q40060938-20C82282-2E0A-484C-A291-06B69D9F1BD2Q40707094-A33A8B02-54CB-4367-AF0A-31B3AF286E01Q40962026-28340401-52C6-4B55-9762-E73F47B1B1B8Q44316617-10411BFB-737C-4A35-9B47-47434E3AEC39Q53139739-2940185C-9E4F-4774-8513-AA308F6F1C53Q53342022-9EC9DF74-49DC-4AF2-B5C6-5D39461AE190Q55261061-95DB3D08-9511-4B78-B087-39E49EF8F219Q55286343-8BD4CF1D-A811-4A8B-BDF6-D6E460AF6952
P2860
Complications after radical gastrectomy following FOLFOX7 neoadjuvant chemotherapy for gastric cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Complications after radical ga ...... emotherapy for gastric cancer.
@ast
Complications after radical ga ...... emotherapy for gastric cancer.
@en
type
label
Complications after radical ga ...... emotherapy for gastric cancer.
@ast
Complications after radical ga ...... emotherapy for gastric cancer.
@en
prefLabel
Complications after radical ga ...... emotherapy for gastric cancer.
@ast
Complications after radical ga ...... emotherapy for gastric cancer.
@en
P2093
P2860
P356
P1476
Complications after radical ga ...... hemotherapy for gastric cancer
@en
P2093
Lian-Hai Zhang
Xiang-Long Zong
Xiao-Jiang Wu
Zhao-De Bu
P2860
P2888
P356
10.1186/1477-7819-9-110
P577
2011-09-26T00:00:00Z
P5875
P6179
1015829011